Identification of surface proteins in Enterococcus faecalis V583 by Bøhle, Liv Anette et al.
RESEARCH ARTICLE Open Access
Identification of surface proteins in
Enterococcus faecalis V583
Liv Anette Bøhle
1, Tahira Riaz
1, Wolfgang Egge-Jacobsen
2, Morten Skaugen
1, Øyvind L Busk
1,
Vincent GH Eijsink
1, Geir Mathiesen
1*
Abstract
Background: Surface proteins are a key to a deeper understanding of the behaviour of Gram-positive bacteria
interacting with the human gastro-intestinal tract. Such proteins contribute to cell wall synthesis and maintenance
and are important for interactions between the bacterial cell and the human host. Since they are exposed and
may play roles in pathogenicity, surface proteins are interesting targets for drug design.
Results: Using methods based on proteolytic “shaving” of bacterial cells and subsequent mass spectrometry-based
protein identification, we have identified surface-located proteins in Enterococcus faecalis V583. In total 69 unique
proteins were identified, few of which have been identified and characterized previously. 33 of these proteins are
predicted to be cytoplasmic, whereas the other 36 are predicted to have surface locations (31) or to be secreted
(5). Lipid-anchored proteins were the most dominant among the identified surface proteins. The seemingly most
abundant surface proteins included a membrane protein with a potentially shedded extracellular sulfatase domain
that could act on the sulfate groups in mucin and a lipid-anchored fumarate reductase that could contribute to
generation of reactive oxygen species.
Conclusions: The present proteome analysis gives an experimental impression of the protein landscape on the cell
surface of the pathogenic bacterium E. faecalis. The 36 identified secreted (5) and surface (31) proteins included
several proteins involved in cell wall synthesis, pheromone-regulated processes, and transport of solutes, as well as
proteins with unknown function. These proteins stand out as interesting targets for further investigation of the
interaction between E. faecalis and its environment.
Background
Enterococci are versatile Gram-positive bacteria that can
survive under harsh conditions. Most enterococci are
non-virulent and commonly found in fermented food
and in the gastrointestinal (GI) tract of humans and ani-
mals. Other strains are opportunistic pathogens that
contribute in a large number of nosocomial infections
worldwide [1]. The mechanism underlying the switch
from a harmless microbe into a life-threatening patho-
gen entering the host bloodstream is not well known.
It is believed that the bacteria normally are well con-
trolled in the GI tract of healthy individuals, whereas a
weakened host immune system and/or development of
bacterial traits to occupy new niches may lead to
translocation to the bloodstream [2]. The past decade
has shown a dramatic increase in antibiotic resistance of
Enterococcus species, creating an increased need for
developing new ways to combat these bacteria. To
achieve this, in-depth insight in the physiology, virulence
and epidemiology of enterococci is required.
Enterococcus faecalis is one of the most frequent Enter-
ococcus species in the GI tract [3,4] and accounts for at
least 60% of the bacteraemia caused by Enterococcus spe-
cies [1]. The genome sequence of three E. faecalis strains
(V583; [5], OG1RF [6], Symbioflor 1 [7]) have been com-
pleted, and several genome projects are ongoing. In the
genome sequence of E. faecalis V583, a vancomycin resis-
tant clinical isolate, over a quarter of the genome consists
of mobile or foreign DNA, including pathogenicity
islands. The abundance of mobile elements in E. faecalis
probably contributes to accumulation of virulence and
drug determinants. Several studies have revealed proteins
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any medium, provided the original work is properly cited.that contribute to the virulence of E. faecalis [8-10], but it
has so far not been possible to link virulence to one or
very few key gene products. Since virulence depends on
the ability to colonize the GI tract and interact with host
cells and proteins in the GI tract, secreted proteins and
proteins located on the cell surface are thought to be
important. One well-studied secreted virulence factor is
cytolysin, which is toxic or lytic to bacterial and human
cells [9,11]. Several adhesion factors facilitating binding
to mucosal and epithelial surfaces have been reported [2].
In addition to involvement in adhesion, surface proteins
may affect virulence in other ways, for example by invol-
vement in cell-cell signalling [9], interactions with the
host immune system, sensing environmental factors, or
protection from environmental factors.
To understand the success of bacterial pathogens and
their adaption to the GI tract it is important to get an
impression of the repertoire of surface associated pro-
teins. According to the LocateP database [12], which
contains genome-wide predictions for the subcellular
locations of bacterial proteins, 306 proteins in E. faecalis
are predicted to be covalently anchored to cell surface,
primarily via N-terminal or lipid anchors. Another 67
are predicted to be secreted or non-covalently attached
to the surface. There is only limited experimental data
supporting these predicted locations [13]. Furthermore,
despite their expected importance for bacterial beha-
viour and impact, the function of most of the predicted
surface and secreted proteins remains unknown.
In the past decade, the extracellular proteomes of sev-
eral Gram-positive bacteria have been analyzed using
proteomics approaches. Many of these studies employed
some kind of protein extraction methods from culture
supernatants and/or cell wall fractions followed by two-
dimensional electrophoresis and mass spectrometry-
based protein identification (e.g. [14-18]). Recently,
more direct and rapid methods for the “in situ” identifi-
cation of surface proteins have been developed which
are based on “shaving” the surface of intact bacteria
with proteolytic enzymes, followed by identification of
the released peptides by liquid chromatography (LC)
and tandem mass spectrometry (MS/MS) [19]. An
advantage of this approach is that the proteolytic
enzymes will only have access to proteins that are
exposed on the surface of the bacterial cell, which could
limit contamination with intracellular proteins. This
approach should in principle be biased towards proteins
that are of particular importance for bacterial interac-
tions with the environment. Indeed, the “shaving”
approach has been applied successfully in the search for
new bacterial epitopes. In a landmark study, Rodriguez-
Ortega et al [19] identified in total 72 proteins in Strep-
tococcus pyogenes M1_SF370 by shaving the bacterial
surface with trypsin or proteinase K. The identified
proteins included known protective antigens and also
revealed new promising candidate antigens for vaccine
development.
In the present study, we have applied the “shaving”
approach to identify the surface proteome of E. faecalis
V583. Cells were treated with free trypsin or trypsin
anchored to agarose beads to shave off and digest surface-
exposed proteins. Using a combination of experiments, 69
surface-located proteins were identified, including proteins
assumed to be involved in pathogenicity and several pro-
teins with unknown function. We also identified proteins
that are thought to be cytoplasmic, but which tend to be
found at bacterial surfaces too. We discuss the putative
roles and relevance of several of the identified proteins
and we compare the various approaches. The results pro-
vide a basis for the identification and further study of
novel proteins putatively involved in pathogenicity and
adaptability of E. faecalis V583.
Methods
Culture conditions and surface shaving
Overnight cultures of E. feacalis V583 [5] were diluted
in fresh prewarmed brain heart infusion (BHI) medium
(Oxoid Ltd., Hampshire, England) to an OD600~0.2 and
incubated at 37°C without agitation. The bacteria were
harvested on the transition between late exponential
and stationary phase (OD600~1.7) by centrifugation
(3000 × g, 10 min, 4°C). The cell pellet from 100 ml of
culture was washed three times with 10 ml PBS by cen-
trifugation (3000 × g, 10 min, 4°C) and subsequently
resuspended in PBS containing 40% sucrose. Three dif-
ferent shaving reactions were set-up, all containing
5 mM DTT and all with the same final concentration of
cells: (1) addition of 20 μg trypsin (Promega, Mannheim,
Germany), (2) addition of trypsin-agarose (100 units;
Invitrogen, Karlsruhe, Germany), or (3) no addition of
trypsin (untreated). The samples were incubated for 1
or 2 hours at 37°C with shaking at 300 rpm. After incu-
bation the cells were pelleted by centrifugation (3000 ×
g, 10 min) and the supernatants were collected for
further protein digestion with 1 μg freshly added trypsin
o v e rn i g h t( 1 6 - 1 8h )a t3 7 ° Cw i t ha g i t a t i o na t4 0 0r p m .
Cell samples taken before (i.e. after resuspending in
PBS) and after the different enzymatic treatments were
used to test cell viability by plating appropriate dilutions
on BHI agar plates and counting of colony forming
units (CFU). The overnight trypsin digestion of the
supernatants was stopped by adding formic acid to a
final concentration of 0.1% (v/v). Prior to nanoLC-MS/
MS analysis, peptides were concentrated and purified in
two steps using C18 Dynabeads (Invitrogen) in the first
step and C18 StageTips [20] in the second step. For
each treatment, samples from four biological replicates
were analysed.
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trypticpeptides
Reverse phase (C18) nano online liquid chromatographic
MS/MS analyses of tryptic peptides were performed
using a HPLC system consisting of two Agilent 1200
HPLC binary pumps (nano and capillary) with corre-
sponding autosampler, column heater and integrated
switching valve. This LC system was coupled via a
nanoelectrospray ion source to a LTQ-Orbitrap mass
spectrometer (Thermo Fisher Scientific, Bremen, Ger-
many). For the analyses, the peptide solution was
injected onto the 5 × 0.3-mm extraction column filled
with Zorbax 300 SB-C18 of 5-μm particle size (Agilent,
Waldbronn, Germany). Samples were washed with a
mobile phase consisting of 97% 0.1% formic acid & 3%
acetonitrile. The flow rate of 4 μl/min provided by the
capillary pump. After 7 min, the switching valve of the
integrated switching valve was activated, and the pep-
tides were eluted in the back-flush mode from the
extraction column onto a 150 × 0.075-mm C18,3 - μm
resin, column (GlycproSIL C18-80Å, Glycpromass,
Stove, Germany). The mobile phase consisted of aceto-
nitrile and MS grade water, both containing 0.1% formic
acid. Chromatographic separation was achieved using
a binary gradient from 5 to 55% of acetonitrile in
1 2 0m i n .T h ef l o wr a t eo f0 . 2μlm i n
-1 was provided by
the nanoflow pump.
Mass spectra were acquired in the positive ion mode
applying a data-dependent automatic switch between
survey scan and tandem mass spectra (MS/MS) acquisi-
tion. Peptide samples were analyzed by collision induced
dissociation (CID) in the LTQ ion trap by acquiring one
Orbitrap survey scan in the mass range of m/z 380-2000
followed by CID of the six most intense ions in the
i o nt r a p .T h et a r g e tv a l u ei nt h eL T Q - O r b i t r a pw a s
1,000,000 for survey scan at a resolution of 60,000 at m/
z 400 using lock masses for recalibration to improve the
mass accuracy of precursor ions. Fragmentation was
performed with a target value of 5,000 ions. The ion
selection threshold was 500 counts. Selected sequenced
ions were dynamically excluded for 180 s.
MS data analysis
Mass spectrometric data were first analyzed by generat-
ing msf files from raw MS and MS/MS spectra using
the Proteome Discoverer 1.0 software (Thermo Fisher
Scientific) and the database searches were then per-
formed with an in house maintained E. faecalis V583
protein sequence database, using the SEQUEST search
engine. The following criteria were applied; database
decoy, true; Enzyme name, trypsin (full); Missed
cleavage sites, 2; Precursor mass tolerance, 10 ppm;
fragment mass tolerance: 0.6 Da; dynamic modificat-
ions: N-term acetyl (any N-terminus), oxidation (M),
carboxymethyl (C), deamidated (N, Q). Proteins were
considered as significant hits if the following conditions
were met: XCorr higher than 2.0; false discovery rate
less than 5%; identified by at least two different peptides;
identified in at least two of the independent parallels by
at least one peptide in each.
SDS-PAGE analysis
To visualize proteins or protein fragments that were
resistant to trypsin, 20 μlo ft h es u p e r n a t a n tf r o mt h e
over-night trypsination were applied to 10% NuPAGE
Novex Bis-Tris gels (Invitrogen). Only samples after
two-hour incubation were studied. The gels were stained
using SilverSNAP Stain for Mass Spectrometry (Pierce,
Rockford, IL) following the manufacturer’s procedure.
After the silver staining, the gel-lane was sliced into 12
pieces, and destained using the protocol included in Sil-
verSNAP Stain for Mass Spectrometry kit. Each gel
piece was then incubated with 0.1 μgt r y p s i ni n2 5μl
25 mM ammonium bicarbonate, over night at 37°C and
400 rpm. The trypsin reactions were stopped by adding
0.1% formic acid. The supernatants were transferred to
new tubes, and the rest of the peptides were extracted
from the gel pieces by incubating with 0.1% (v/v) tri-
fluoroacetic acid in 60% (v/v) acetonitrile, at 37°C,
400 rpm for 10 min. The extracts from three gel-pieces
were pooled together (giving four samples from each
treatment). The peptides were dried in a speed-vac, and
rehydrated in 30 μl 0.1% (v/v) TFA. The peptide sam-
ples were desalted using C18 stage tips [20] prior to
nanoLC-MS/MS. Proteins were considered as significant
hits if the following conditions were met: XCorr higher
than 2.0; false discovery rate less than 5%; identified by
at least two different peptides; identified in at least one
of the three samples from each treatment.
Bioinformatic analysis of protein localization
Protein sequences used for in computo analysis of the
localization of the identified proteins were extracted
from the LocateP database [12] and analyzed using sev-
eral bioinformatic tools. Putative N-terminal signal
sequences and cleavage sites were predicted using the
Signal P 3.0 server [21] and LipoP v 1.0 [22]. The
TMHMM Server v. 2.0 [23] was used to predict proteins
with multiple transmembrane helices or N-terminal
transmembrane anchors. Proteins with features indicat-
ing non-classical secretion were predicted using the
SecretomeP 2.0 Server [24]. Domain annotations were
done using Pfam [25]. After these verifications, the pre-
dicted localizations for 62 oft h e6 9p r o t e i n sd i s c u s s e d
below correspond to those given in the LocateP data-
base (updated March 10, 2010). For seven proteins,
we reached a different conclusion than LocateP, as
described in results and discussion.
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Protein identification
Before carrying out the experiments, we performed
extensive tests to find optimal conditions for the trypsin
treatment. Most importantly, we checked the effect of
incubation time (30 min to 24 hours) on cell viability.
Incubation times of 2 hours or less did not lead to sig-
nificant reductions in the CFU number (Additional file
1), whereas longer incubation times led to decreased
viability (data not shown). Based on these observations,
incubation times were set to one or two hours. Two
hour incubations led to a high e rn u m b e ro fi d e n t i f i e d
proteins (Additional file 2). Generally, the longer incu-
bations did not lead to an increase in the fraction of
cytoplasmic proteins, confirming the absence of cell
lysis during the enzymatic treatment (Additional file 2).
Intact bacterial cells were harvested and treated with
either trypsin or trypsin beads (trypsin bound to agarose
beads) for one or two hours. Because trypsin beads are
less likely to penetrate the cell wall than free trypsin, they
are more likely to only act on proteins that protrude
from the cell wall. As a control, cells were incubated for
one or two hours without adding trypsin. Direct analysis
of released tryptic peptides led to the identification of 57
unique proteins (Table 1). Subsequent analysis of solubi-
lized proteins and large protein fragments using SDS-
PAGE followed by MS-based identification (Figure 1; see
Materials and Methods) led to the identification of
another 12 unique proteins (Table 2). The sequences of
all identified proteins were analysed using a variety of
bioinformatic tools (LocateP, SignalP, Pfam, LipoP,
pSORT and TMHMM) to verify or (for EF2860, EF0071,
EF0123, EF0164, EF0394, EF0417 & EF_B0004) to adjust
the localization given in the LocateP database. The
results are incorporated in Table 1 & 2 and are discussed
in appropriate sections, below.
Analysis with Signal P 3.0 [21] suggested the presence
of a signal peptidase I (SPase I) cleavage site in ten of
the identified proteins. Four of these proteins contained
a putative C-terminal LPxTG motif, whereas one addi-
tional protein (EF2860) is likely to be cell-wall anchored
because it contains a putative peptidoglycan binding
domain (Pfam PF12229). It should be noted that the
sequences deposited in the GenBank database for two of
the four LPxTG-containing proteins (EF1033 and
EF2713) lack a predicted N-terminal signal sequence.
A closer look at the upstream sequences showed that
the start codons probably are located 72 and 96 nucleo-
tides upstream of the start codon suggested in the
GenBank entries, for EF1033 and EF2713, respectively
(Additional file 3). After this N-terminal “extension”
SignalP and LipoP detected a putative SPase I cleavage site
in both sequences.
Table 3 gives an overview over the predicted localiza-
tions of the 69 identified unique proteins and shows
that the methods yielded a strong bias towards identify-
ing proteins that are predicted to be covalently anchored
to the cell wall or to carry lipid anchors. Several pro-
teins were identified in more than one experiment and
an overview is provided in Figure 2. Treatment with free
trypsin yielded 58 proteins and treatment with trypsin
beads yielded 29 proteins. Analysis of samples from
untreated cells yielded 16 proteins. More detailed infor-
mation concerning the numbers of proteins identified
after the various treatments is provided in additional file
2. Details of the proteomic analysis are provided in
Additional file 4 and Additional file 5 containing Tables
S5 and S6, respectively.
The number of proteins only identified after a “shav-
ing” treatment amounted to 53. Nine of these were only
found after treatment with trypsin beads, 38 were only
found after treatment with free trypsin and six were
found after both treatments (Figure 2). The 15 proteins
identified with only trypsin-beads or with both trypsin
and trypsin beads are likely to be exposed on the surface
of the cell wall, whereas the 38 unique proteins found in
the free trypsin samples fraction are probably localized
deeper in the cell wall.
Of the 16 proteins identified from untreated cells, 12
were identified in all three treatments (Figure 2). While
three of these are predicted to be secreted and one
(EF0201) is probably cytoplasmic, the others are pre-
dicted to be attached to the bacterial surface through
an anchor (five lipo-anchors and one LPxTG anchor)
or cell wall binding domain (one, EF2860) or even as
integral membrane protein (one, EF1264). The trypsin-
independent release of these proteins may be a result of
natural shedding, a phenomenon that indeed has been
observed previously, in particular for lipoproteins
[15,26]. According to a TMHMM topology prediction
EF1264, annotated as membrane protein, contains five
N-terminal transmembrane helices and a huge extracel-
lular domain with putative sulfatase activity of 523 resi-
dues (starting at amino acid 179). EF1264 was identified
by many significant peptide hits spread over all treat-
ments. Figure 3 shows that all identified peptides
stem from the extracellular domain and that there is a
115 amino acid gap between the predicted integral
membrane domain and the first identified tryptic frag-
ment. Perhaps the extracellular domain is shedded after
natural cleavage of EF1264. It is conceivable that such
(apparently rather abundant) shedding is a physiologi-
cally relevant phenomenon since the sulfatase may
remove sulphate from mucin, which would allow more
easy degradation of mucin by glycosidases [27] and per-
haps also could facilitate bacterial adhesion.
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Page 4 of 14Table 1 Proteins identified by LC-MS/MS analysis of tryptic fragments obtained after different treatments of intact E. faecalis V583
Peptide hits
d
Gene Pfam
a Gene product
b Predicted
localization
c
Un-treated
1h o u r
Un-treated
2 hours
Trypsin 1
hour
Trypsin 2
hours
Beads 1
hour
Beads 2
hours
Total
cover-age
%
EF_B0004
e Bacterial extracellular solute-
binding proteins, family 5
TraC protein Cell wall 2 2 (1) (1) 13.0
EF0071 Contains trehalase domain Putative lipoprotein Lipid anchor SP-II,
VVS-CF
(3) 2 10.0
EF0123 Contains nine Clostridial hydro-
phobic W domain
Hypothetical protein Secreted SP-I, AYA-LE 5 2 9 7 (1) 4 23.2
EF0164 Putative lipoprotein Lipid anchor SP-II,
FTS-CG
2 3 2 3 2 32.3
EF0176
f Basic membrane protein Hypothetical protein Lipid anchor SP-II,
LAA-CG
3 5 2 25.7
EF0177
f Basic membrane protein Hypothetical protein Lipid anchor SP-II,
LAA-CG
5 7 2 32.1
EF0195
g Phospho-glycerate mutase 1 Cytoplasmic 2 (1) 10.5
EF0199
g 30S ribosomal protein S7 Cytoplasmic 2 30.1
EF0200
g Elongation factor G Cytoplasmic (1) 7 7 22.4
EF0201
fg Elongation factor Tu Cytoplasmic (1) 2 11 8 5 4 47.1
EF0205 30S ribosomal protein S10 Cytoplasmic 2 (1) 29.4
EF0206
g 50S ribosomal protein L3 Cytoplasmic 2 5 23.4
EF0207
g 50S ribosomal protein L4 Cytoplasmic (1) 2 15.9
EF0211 50S ribosomal protein L22 Cytoplasmic (1) 2 2 (1) (1) 17.4
EF0218
g 50S ribosomal protein L5 Cytoplasmic (1) 3 21.2
EF0221
g 50S ribosomal protein L6 Cytoplasmic (1) 3 27.0
EF0223 50S ribosomal protein L18 Cytoplasmic (1) 2 39.0
EF0226 50S ribosomal protein L15 Cytoplasmic (1) (2) 2 (1) (1) (1) 21.2
EF0228 Adenylate kinase Cytoplasmic 2 2 19.4
EF0234
g 50S ribosomal protein L17 Cytoplasmic 2 (1) 26.0
EF0304 - Putative lipoprotein Lipid anchor SP-II,
LSA-CS
(1) 2 2 20.5
EF0394 Cysteine-rich secretory protein
family
Secreted antigen, putative Secreted SP-I, ALA-DN 2 3 (1) 17.8
EF0417 - Hypothetical protein Secreted SP-I, VNA-LN 3 2 4 4 3 11.2
EF0502 - Hypothetical protein Multiple
transmembrane
proteins
2 7.9
EF0633 tyrosyl-tRNA synthetase Cytoplasmic 2 6.9
EF0685
f Rotamase family protein Lipid anchor SP-II,
LAA-CS
2 10.8
EF0737 Amidase N-terminal anchor 2 6.8
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4Table 1 Proteins identified by LC-MS/MS analysis of tryptic fragments obtained after different treatments of intact E. faecalis V583 (Continued)
EF0907
f - Peptide ABC transporter peptide-
binding protein
Lipid anchor SP-II, LAA-
CG
2 16.4
EF0916 50S ribosomal protein L20 Cytoplasmic (1) (1) 2 27.7
EF0970
e 50S ribosomal protein L27 Cytoplasmic 2 2 34.7
EF0991 Penicillin-binding protein C N-terminal anchor (1) 2 11.2
EF1033 Lipoamidase Cell wall anchored
LPxTG SP-I, AQE-SI
2 2 4.7
EF1046
g Pyruvate kinase Cytoplasmic (2) (2) 2 11.6
EF1167
g Fructose-bisphosphate aldolase Cytoplasmic (1) (2) 2 4 3 (1) 30.8
EF1264
f Sulfatase domain-containing
protein
Multiple trans-
membrane proteins
2 10 11 (1) 5 29.8
EF1308
fg Dnak protein Cytoplasmic (1) 2 3 23.7
EF1319 - Hypothetical protein N-terminal anchor (1) 3 23.3
EF1379 Alanyl-tRNA synthetase Cytoplasmic 2 3.3
EF1420 - Hypothetical protein Lipid anchor SP-II, MTA-
CS
2 (1) 15.6
EF1523
e - Hypothetical protein Cytoplasmic (1) 3 6.4
EF1613
fg Formate acetyltransferase Cytoplasmic 3 (2) 13.4
EF1818
f Coccolysin Secreted SP-I, VAA-EE 8 3 8 5 (1) 2 45.1
EF1898 50S ribosomal protein L19 Cytoplasmic (1) 2 30.4
EF1961
fg Enolase Cytoplasmic 2 4 (1) 25.7
EF1964
fg Glycer-aldehyde-3-phosphate
dehydrogenase (GAPDH)
Cytoplasmic 3 8 36.0
EF2144 - Putative lipoprotein Lipid anchor SP-II LTA-
CS
(1) 2 (1) 2 22.4
EF2174 Glycosyl hydrolases family 25 Hypothetical protein Secreted SP-I, ASG-EE 3 4.5
EF2398
g 30S ribosomal protein S2 Cytoplasmic (1) 2 4 2 (1) 19.2
EF2556
f Fumarate reductase flavoprotein
subunit
Lipid anchor SP-II, ATG-
CT
40 39 40 41 22 37 79.2
EF2718
ge 50S ribosomal protein L1 Cytoplasmic 2 2 24.0
EF2746 DltD protein N-terminal anchor (1) 2 2 3 (1) 2 10.4
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4Table 1 Proteins identified by LC-MS/MS analysis of tryptic fragments obtained after different treatments of intact E. faecalis V583 (Continued)
EF2860
f YkuD putative, peptido-glycan
binding domain
Cell wall, SP-I VYF-QS, 2 6 5 9 (1) 7 36.3
EF2864 - Hypothetical protein Lipid anchor SP-II,
LTA-CR
2 2 3 4 2 2 25.7
EF2925
g Cold-shock domain-contain
protein
Cytoplasmic (1) 2 (1) 2 45.5
EF3041
f Pheromone binding protein Lipid anchor SP-II,
LAA-CG
2 3 2 7 2 24.3
EF3256
f Pheromone cAD1 precursor
lipoprotein
Lipid anchor SP-II,
LAA-CG
(1) 2 19.4
EFA0003 TraC protein Lipid anchor SP-II,
LGA-CN
2 9.4
Further details on the Sequest-based protein identification process are provided in the Materials and Methods section and in Table S5 (Additional file 4).
aSignificant hits (or absence thereof, indicated by -) obtained after searches in Pfam [25] for putative and hypothetical proteins.
bAll data extracted from the LocateP database [12] with two exceptions: EF1033 (annotated as 6-aminohexanoate-cyclic-dimer hydrolase; annotated as putative, in LocateP) and EF2860 annotated as ErfK/YbiS/YcfS/
YnhG family protein; annotated as putative, in LocateP).
cPredicted localization and potential cleavage site. Localization is based on LocateP annotations, with seven exceptions (for Tables 1 and 2 in total) that are all explicitly mentioned in the text. See also Table 3.
dThe column shows the number of peptide hits from four biological replicates. Protein identifications were considered significant using the criteria described in Materials and Methods. One criterium was the
detection of at least two different peptides; another the detection of peptides in at least two independent parallels; these criteria are met for all listed proteins. Putative, non-significant additional identifications of
these proteins (based on just one peptide and/or on just one parallel) are indicated in parentheses.
eSecretomeP value >0.5; this means that the protein is predicted to be secreted via a “non-classical” pathway.
fProteins that have been identified as being localised on the surface in a previous study of E. faecelis JH2-2 [13].
gCytoplasmic proteins that have been identified in other studies of the surface proteomes of Gram-positive bacteria. See text for references.
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4Cytoplasmic proteins
According to the LocateP database 34 of the 69 identi-
fied proteins lack an N-terminal signal sequence and are
therefore predicted to be cytoplasmic proteins. All these
proteins were analysed using PSORTb v.3.0 [28] and the
SecretomeP (SecP) 2.0 Server [24,29]. SecP predict pro-
teins that are putatively secreted without having a
detectable N-terminal signal sequence, i.e. by “non-clas-
sical secretion”. Analysis with SecP indicated that four
of the proteins predicted to be cytoplasmic (EF0970,
EF1523, EF2718 and EF_B0004) may follow non-classical
secretion. PSORTb predicted EF_B0004 (TraC protein)
to be a cell wall protein and Pfam gave a significant hit
against “Bacterial extracellular solute-binding proteins,
family 5” (PF00496). It has been shown that TraC pro-
teins play a role as surface pheromone receptor and are
thereby involved in the regulation of the conjugation
process [30,31]. Therefore, EF_B0004 was classified as a
cell wall protein in this study. The other three proteins
were retained as cytoplasmic, despite the fact that
PSORTb predicted EF0970 (ribosomal protein L27) to
have an extracellular location.
Identification of cytoplasmic proteins at extracellular
locations is not unusual and at least 20 of the 33 proteins
found in this study have been identified in previous stu-
dies of the secretomes or surface proteomes of Gram-
positive bacteria (Tables 1 and 2) [13,18,26,32-36]. The
majority of the identified cytoplasmic proteins were
unique to the trypsin fraction and/or the beads fraction,
indicating that these proteins bind to the cell envelope
and need to be “shaved” from the surface, despite the
lack of known binding motifs or domains. Many of the
identified cytoplasmic proteins are highly abundant pro-
teins like ribosomal proteins (Rbps; more than 20% of all
identified proteins), EF-Tu/G, GADPH and chaperones,
which suggests that cell lysis rather than an unknown
active secretion process determines their extracellular
presence. While the cell viability checks described above
indicate that cell lysis due to the trypsin treatment is
unlikely, it is conceivable that cell lysis in the cell culture
prior to the trypsin treatment may have released intracel-
lular proteins that somehow have re-associated with the
cell envelope and escaped proteolytic degradation [26,37].
While cytoplasmic proteins found in studies such as
the present generally must be considered contaminants,
there have been speculations in the literature that some
of these actually may have extracellular functions. One
example is Rbp L7/L12 (EF2715) which has been identi-
fied at the surface of several Gram positive bacteria
[19,26,34,35,38]. We found Rbp L7/L12 in the beads
fraction only and this implies an exposed localization,
similar to the localization suggested in B. subtilis [26].
Bacterial Rbp L7/L12 has immunogenic properties in
humans [38,39] and is being explored as candidate
Figure 1 SDS-PAGE analysis of the supernatants obtained after
treating intact cells with trypsin; see materials and methods
for details. The gel shows the results from cells treated with
trypsin, cells treated with trypsin beads and a control sample
("untreated”) where no trypsin was added. Samples sizes represent
approximately the same amount of cells in all lanes.
Table 3 Summary of the identified proteins grouped
according to predicted localization
Predicated
localization
a
Number of
identified unique
proteins
Number in the
E. faecalis V583
genome
b
Percent
identified
Cytoplasmic 33 2303 1.4
Membrane
c 3 588 0.5
Lipid anchor 17 74 23.0
N-terminal
anchor
5 190 2.6
LPxTG
proteins
4 38 10.5
Cell wall
associated
2N D
d ND
d
Secreted 5 59 8.5
C-terminal
anchor
04 0
Secreted via
minor
pathway
08 0
Sum 69 3264 2.1
a Localization data are from LocateP (Zhou et al., 2008), with the seven
corrections described in the text. According to Locate P, the numbers of
identified cytoplasmic, lipid anchor, N-terminal anchor, cell wall associated
and secreted proteins.
b Data from the LocateP database.
c Containing multiple transmembrane helices.
d Not detected (ND), LocateP only predicts cell wall proteins with LPxTG
motifs.
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Page 8 of 14antigen for vaccine purposes [40,41]. Recent data
showed that exposure of bacterial Rbp L7/L12 is a risk
factor for colorectal cancer and stimulates progression
of adenomas into carcinomas [42]. There has also been
some speculation about possible adhesive roles of extra-
cellular EF-Tu, DnaK, enolase and GAPDH, all identi-
fied in the present study and in a recent study of the
laboratory strain Enterococcus faecalis JH2-2 [13], since
these proteins bind strongly to human plasminogen [32].
Secreted proteins
Proteins were annotated as being secreted to the culture
medium if the bioinformatic analyses showed the presence
of a SPaseI cleavage site and did not reveal any sequence
or domain known to be involved in covalent or non-cova-
lent binding to the cell wall. Only five such proteins were
identified indicating that few secreted proteins are closely
associated to the microbe. Three of the secreted proteins
(EF0123, EF0394, EF0417) are annotated as N-terminally
anchored in the LocateP database. It is, however, not easy
to differentiate between secreted proteins with processed
signal peptides and proteins that retain their signal pep-
tides as N-terminal membrane anchors [12]. The Signal P
server predicted all three proteins to contain a unique
cleavage site, when using both algorithms in the program.
All three were detected even without trypsin treatment,
suggesting a loose association with the cell envelope.
Taken together, we conclude that EF0123, EF0394 and
EF0417 are secreted proteins.
EF2174 was detected after trypsin treatment only and
putatively encodes a glycoside hydrolase belonging to
family GH25 [43]. This family comprises enzymes with
lysozyme activity that are thought to be involved in pep-
tidoglycan remodelling during cell division [44].
The well known secreted metalloprotease coccolysin, a
gelatinase (EF1818; GelE) was identified after all treat-
ments (Table 1), indicating that GelE is loosely associated
to the cell surface. Coccolysin is known to be associated
with virulence and is capable of degrading cellular tissues
during infection, cleaving substrates such as haemoglobin,
collagen and fibrin [45,46]. There are also indications that
GelE is required for biofilm formation [47].
Proteins on the surface
Among the 31 non-secreted non-cytoplasmic proteins
found in this study (Table 3), three are annotated as
Table 2 Additional proteins identified using the SDS-PAGE approach after different treatments
Peptide hits
d
Gene Pfam
a Gene products
b Predicted localization
c Untreated
2 hours
Trypsin
2 hours
Beads
2 hours
Coverage
%
EF0517
f 2-dehydropantoate 2-reductase Cytoplasmic 2 13.1
EF0968
f 50S ribosomal protein L21 Cytoplasmic 2 35.3
EF2221 ABC transporter. substrate-binding
protein
Lipid anchor SP-II,
LSA-CG
2 8.8
EF2224 Four DUF11
repeats
Cell wall surface anchor family
protein
Cell wall, LPxTG, SP-I,
MNA-FA
2 1.4
EF2633
f Chaperonin. GroEL Cytoplasmic 4 9.2
EF2713 Gram positive
anchor
Cell wall surface anchor family
protein
Cell wall, LPxTG, SP-I
VWA-ED
2 9.4
EF2715
f Ribosomal protein L7/L12 Cytoplasmic 2 29.5
EF2857
e Penicillin-binding protein 2B N-terminal anchor 3 4.8
EF2903
e ABC transporter, substrate-binding
protein
Lipid anchor SP-II,
LGA-CG
6 2 20.2
EF3106
e Peptide ABC transporter. peptide-
binding protein
Lipid anchor SP-II,
LAA-CG
2 3.4
EF3257 Pyridine nucleotide-disulfide family
oxidoreductase
Multiple transmembrane
proteins
2 7.3
EFA0052 Surface exclusion protein Sea1 Cell wall LPxTG SP-1,
VQA-AE
2 2 2 6.3
The gel approach yielded 25 unique proteins in total but only 12 of these were novel compared to the list of Table 1; see Additional file 2 for more details.
Further details on the Sequest-based protein identification process are provided in the Materials and Methods section and in Table S6 (Additional file 5).
aSignificant hits obtained after searches in Pfam [25] for putative and hypothetical proteins.
bData extracted from the LocateP database [12].
cPredicted localization and potential cleavage site. Localization is based on LocateP annotations, with seven exceptions (for Tables 1 and 2 in total) that are all
explicitly mentioned in the text. See also Table 3.
dNumber of peptide hits in each of the three treatments. Protein identifications were considered significant using the criteria described in Materials and Methods.
Proteins were only considered a significant hit if at least two unique peptides were found.
e Proteins that have been identified as being localised on the surface in a previous study of E. faecelis JH2-2 [13].
fCytoplasmic proteins that have been identified in other studies of the surface proteomes of Gram-positive bacteria. See text for references.
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Page 9 of 14integral membrane proteins. We identified only 0.5% of
the predicted transmembrane proteins in the genome
of E. faecalis V583 (Table 3). Such low numbers of
identified transmembrane proteins are not unusual
[19,26,37,48] and are likely to be due to limited accessi-
bility of the proteins and/or a limited ability of trypsin
to penetrate the cell wall. One of these transmembrane
proteins, the sulfatase (EF1264), was detected by many
peptides after all treatments (see above and Figure 3).
The other two were only detected after trypsin treat-
ment and only by a minimal number of peptides.
EF0502 is a 781-residue hypothetical protein which
according to topology predictions contains several extra-
cellular domains. Both detected peptides are predicted
to have an extracellular location. EF3257 is a 648-resi-
due oxidoreductase belonging to the pyridine nucleo-
tide-disulfide family with probably only two trans-
membrane helices and a large extracellular domain.
Both detected peptides stem from extracellular domains.
Five identified proteins are thought to be N-terminally
anchored to the cell membrane via a Sec-type signal
peptide that is not cleaved off during secretion.
Relatively few such proteins were identified (Table 3),
suggesting that they are expressed at low levels or that
they generally have low accessibility for trypsin. Among
these proteins are two penicillin-binding proteins
(EF2857 & EF0991), one amidase (EF0737) and one pro-
tein of unknown function (EF1319). EF2857 and EF0991
are class B penicillin binding proteins (PBP), which are
transpeptidases involved int h ef i n a ls t a g eo fc e l lw a l l
synthesis [49]. E. faecalis has three class B PBPs that
have low affinity for b-lactams and can take over the
transpeptidase activity of more high affinity PBPs when
these are inhibited by antibiotics [50]. We also identified
a L,D-transpeptidase (EF2860; YkuD domain), in all
treatments and with a high number of peptide hits, indi-
cating that this protein is abundant at the surface of
V583. Studies on E. faecium have indicated that L,D-
transpeptidase activity may represent another way to
bypass inhibition of PBPs [51,52].
The fifth protein, DltD (EF2746), is also involved in
the biosynthesis of surface structures. The dltD gene is
part of an operon consisting four genes (dltA-dltD)
whose gene products are all necessary to incorporate
D-alanyl residues into lipoteichoic acids (LTA) [53,54].
It has previously been shown that disruption of genes in
the dlt operon of E. faecalis lead to diminished adhesion
to eukaryotic cells and less biofilm formation, indicating
that the dlt operon is involved in pathogenicity [55].
Interestingly, it is not fully established whether the
N-terminal anchor tethers DltD to the inner or outer
leaflet of the membrane [53,56]. The fact that DltD was
detected after all types of treatments may be taken to
suggest that the protein is attached to the outer leaflet,
as one would expect for proteins using a Sec-type signal
peptide as membrane anchor.
Of the four proteins containing a putative LPxTG
anchor, two (EF2224 & EF2713) have unknown func-
tions. EF2713 is up-regulated when E. faecalis V583 is
grown in the presence of blood [57], indicating a puta-
tive role of this protein in infection processes. The
LPxTG anchor protein EF2224 contains five copies of a
so-called DUF11 repeat with unknown function and is a
putative member of the MSCRAMM (mirobial surface
component recognizing adhesive matrix molecules)
family of proteins [58]. These proteins contain tandemly
repeated immunoglobulin-like folds as observed for sta-
phylococcal adhesins. The E. faecalis V583 genome con-
tains seventeen proteins belonging to the MSCRAMM
family [59]. Interestingly, EF2224 is highly expressed
during the infection process in humans [59].
The LPxTG anchor protein EF1033 is a lipoamidase
(Lpa) cleaving lipoic acids from lipoylated molecules
[60,61]. EF1033 was only detected after trypsin treatment,
indicative of covalent cell wall attachment. Lipoic acid is
an essential sulphur containing cofactor of several
Beads
Cytoplasmic 5
Lipid anchored 1
N-terminal 1
Cell wall 1
Membrane 1
Lipid anchored 4
Cytoplasmic 2
Trypsin
Cytoplasmic 23
Lipid anchored 7
N-terminal 3
Cell wall 3
Membrane  1
Secreted 1
Cytoplasmic 1
Lipid anchored 1
Cytoplasmic 1
Lipid anchored 4
N-terminal 1
Cell wall 2
Membrane  1
Secreted 3
Cytoplasmic 1
Secreted 1
Untreated Trypsin
Cytoplasmic 23
Lipid anchored 7
N-terminal 3
Cell wall 3
Membrane  1
Secreted 1
Cytoplasmic 1
Lipid anchored 1
Beads
Cytoplasmic 5
Lipid anchored 1
N-terminal 1
Cell wall 1
Membrane 1
Cytoplasmic 1
Secreted 1
Lipid anchored 4
Cytoplasmic 2
Cytoplasmic 1
Lipid anchored 4
N-terminal 1
Cell wall 2
Membrane  1
Secreted 3 S S
Figure 2 Overview over the identifcation of 69 surface-located
proteins using various treatments of enterococcal cells. The
putative cellular localizations of the identified proteins, as provided
in Table 3 are indicated. In total 58, 16 and 29 proteins were
identified in the trypsin, untreated and beads samples, respectively.
Note that this figure combines the data from the one and two hour
treatments and includes the data from both the direct LC-MS/MS
analysis and the SDS-PAGE-based approach. More details about the
numbers of identified proteins in the various experiments are
provided in Additional file 2. Proteins containing multiple
transmembrane helices are indicated by “Membrane"; proteins
indicated by “Cell Wall” include 4 proteins with LPxTG anchors and
two proteins containing domains known to display cell wall binding
affinity.
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Page 10 of 14enzymes. Interestingly, so far, E. faecalis is the only bacter-
ial species in which Lpa activity has been detected [61].
Jiang and Cronan [61] speculate that the Lpa is a cytoplas-
mic salvage enzyme, but our experimental and bioinfor-
matic results indicate that the enzyme is a cell wall
anchored protein. Most likely, Lpa recruits its substrates
from the environment, such as the GI tract.
The fourth LPxTG protein is the plasmid encoded
surface exclusion factor Sea1 (EFA0052) which is
involved in the regulation of sex pheromone-controlled
conjugation [62].
EF2860 is linked to the cell wall by a peptidoglucan
binding domain and encodes a cell wall modifying trans-
peptidase homologous with YkuD from Bacillus subtilis.
This protein was found after all three treatments and
identified with relatively many peptide hits (Table 1),
indicating that EF2860 is abundant on the surface and
may show a relatively large extent of shedding. This
protein may contribute to the antibiotic resistance of E.
faecalis, as discussed above.
The most populated group of proteins identified in
this study are the lipoproteins, of which 17 were
10 20 30 40 50 60 70 80
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
MKKLFKTNILNTRLGLFSLIAILLWLKNLFAYAVDFHLRLENINEYFILLINPIATTVFLLAIALYVRRKKASYITMMII
90 100 110 120 130 140 150 160
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
YFLMSLLLFSNVVYYREFTDFITVNTMLGAGKVASGLGESALRLFRPYDVIYFLDFIIIGVLLLTKKIKTDARPVRARVA
170 180 190 200 210 220 230 240
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
VSVTLLSVVFFLFNLFMAETERPQLLGRQFSRDYIVKFLGLNAFTVYDGITTYQTNQVRAEASANDMKQVEDYVKQQYAA
250 260 270 280 290 300 310 320
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
PDDSKFGIAKGKNVIYIHLESFQQFLVNYKLKDENGVEHEVTPFINSLYNSKSTFSFDNFFHQVGQGKTSDAETLLENSL
330 340 350 360 370 380 390 400
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
FGLDQGSLFTQVGGKNTFEAAPDILKQTQGYTSAAFHGNAGNFWNRNETYKRLGYDYFFDASYYDVNSDNSFQYGLHDKP
410 420 430 440 450 460 470 480
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
FFNQSVQYLEHLQQPFYSKFIAVSNHYPYSQFTNDEAGFPIAKTSDETINGYFATANYLDKAVEEFFNYLKSSGLYENSV
490 500 510 520 530 540 550 560
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
IVLYGDHYGVSNSRNQNLAELVGKTKADWNDFDNANMQRVPYMIHVPGQENGGVNHTYGGQVDALPTLLHLLGVDTKNYI
570 580 590 600 610 620 630 640
....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
QLGQDLFSKQHNQIVAFRNGNVVTPKYTILGSSIYDTKTGTLITEPTEEVKKEVADLKAKATKQLETSDQITNGDLLRFY
650 660 670 680 690 700
....|....|....|....|....|....|....|....|....|....|....|....|..
TNSGLKPVNPEDYDYKNQLQQLEAIEKEKGEKSTSVYSKNNNKSTVDEYHTDSYQGYQKTGK

/ŶƚƌĂĐĞůůƵůĂƌ
ǆƚƌĂĐĞůůƵůĂƌ
 dD,
WĞƉƚŝĚĞŚŝƚƐϭŚŽƵƌ;ƵŶƚƌĞĂƚĞĚͿ
WĞƉƚŝĚĞŚŝƚƐϭŚŽƵƌ;ƚƌǇƉƐŝŶͿ
WĞƉƚŝĚĞŚŝƚƐϮŚŽƵƌƐ;ƚƌǇƉƐŝŶͿ
WĞƉƚŝĚĞŚŝƚƐϮŚŽƵƌƐ;ďĞĂĚƐͿ
Figure 3 Amino acid sequence and predicted topology of EF1264. The predicted trans-memberane helices (TMH) and the identified tryptic
peptides after different treatments are mapped on the sequence, using the color coding indicated in the figure.
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Page 11 of 14detected, representing 23% of the lipoproteins putatively
encoded on the E. faecalis genome (Table 3). Twelve of
these were detected only after a “shaving” treatment.
Seven of the detected lipoproteins are proteins with no
predicted function. Two of these unknown lipoproteins
(EF0176 & EF0177) are located on the same operon,
share 70% sequence identity, and contain a “Basic mem-
brane protein” domain (PF02608) belonging to Clan
CL0144 in the Pfam database. This clan consists of pro-
teins that are involved in chemotaxis and membrane
transport of sugars as well as outer membrane proteins
that are known for their antigenicity in pathogenic bac-
teria. Both proteins are homologous with a CD4+ T-
cell-stimulating antigen in Listeria [63]. One of the
other proteins with unknown function, EF0164, is anno-
tated as N-terminally anchored in the LocateP database,
but is classified as a lipoanchored protein on the basis
of our analyses with LipoP.
Of the ten lipoproteins with predicted functions, four
lipoproteins resemble the substrate-binding domains of
multi-component ABC transporters for the import of
peptides (EF0907, EF3106) or sugars (EF2221, EF2903).
Three proteins (EF3041, EF3256, EFA0003) are involved
in pheromone-regulated processes that include conjuga-
tion [31], adding to the two cell wall associated proteins
involved in these processes that are discussed above
(EFB0004 & EFA0052). EF0071 seems to encode a gly-
coside hydrolase belonging to clan GH-G in the CAZy
database. The protein is classified as N-terminally
anchored in the LocateP database, but our analyses with
the LipoP program clearly indicated that EF0071 is a
lipoanchored protein. EF0685 belongs to the rotamase
family and is thus likely to be involved in extracellular
protein folding, possibly by exerting prolyl-peptidyl iso-
merase activity.
The final lipo-anchored protein is EF2556, fumarate
reductase, which was detected by remarkably large num-
bers of peptides after all treatments (Table 1). E. faecalis
is one of few bacteria that produces substantial amounts
of extracellular superoxide. Fumarate reductase is likely
to be involved in superoxide production and may thus
be an important source of oxidative stress for the host
[64]. It has been demonstrated that the superoxide from
E. faecalis promotes chromosomal instability in mam-
malian cells and that this can lead to colorectal cancer
[65,66].
Conclusions
In recent years, several analyses of bacterial surface pro-
teomes have been described. Despite the improvements
in the mass spectrometry methods, the numbers of
identified proteins are normally in the order of 30 - 80,
m e a n i n gt h a to n l yam i n o r i t yo ft h ep u t a t i v es u r f a c e -
located proteins is being found. In this type of studies, it
is common to find a significant fraction of proteins that
are thought to be cytoplasmic and there is some evi-
dence that this is not just the result from artefacts such
as cell lysis. We show that the large majority of the
identified cytoplasmic proteins are only found after
treatment with trypsin. This is an important observation,
since it shows that these proteins bind tightly to the cell
envelope.
In a recent published proteomics-based analysis 38
proteins were identified on the surface of E. faecalis
JH2-2 [13]. Seventeen of these proteins were found after
using a method similar to the one used here (i.e. surface
shaving with trypsin) and seven of these were also found
in the present study (EF0177, EF0201, EF0907, EF1613,
EF1964, EF2556 and EF3256). Disparities between this
type of studies may be due to many factors, e.g. differ-
ences between the strains and growth conditions or dif-
ferences in the confidence of protein identification.
Benachour et al [13] allowed protein identification on
the basis of only one peptide hit, while we required at
least two peptides for confident identification. Large
inter-strain variation has been observed in several pre-
vious studies, both for secreted proteins and for proteins
detected by a trypsin-shaving approach [34,67,68].
In conclusion, our studies reveal 69 surface-located
proteins in E. faecalis V583 with varying roles in bacterial
behaviour. Several of the identified proteins are involved
in cell wall synthesis and maintenance as well as in cell-
cell communication and seem interesting targets for drug
design. We detected only a few proteins with known or
conceivable functions in adhesion, but such proteins may
be among the many identified proteins with unknown
function. Clearly, the identified proteins with unknown
function stand out as targets for more in-depth investiga-
tions and several of these are currently subjected to
knock-out studies in our laboratory.
Additional material
Additional file 1: Figure S1: Control of viability of the cells before
and after incubation for one or two hours with trypsin, trypsin
beads or without any enzyme.
Additional file 2: Table S1-S4: Number of identified proteins in each
treatment PDF.
Additional file 3: Figure S2: Nucleotide and amino acid sequences
of EF1033 and EF2713 after adjustment of the start codon.
Additional file 4: Table S5: Proteome data of the proteins identified
by LC-MS analysis after different treatments.
Additional file 5: Table S6: Proteome data of the proteins identified
using the SDS-PAGE approach after different treatments.
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